Genetic and pharmacological manipulations of the GLO1 system, as well as direct administration of MG, have been associated with changes in anxiety- and depression-like behaviors, ethanol consumption, and the seizure threshold. The gene discussed is GLO1; the disease is depressive symptom measurement.